share_log

Stifel Maintains Hold on MEI Pharma, Lowers Price Target to $9

Benzinga ·  Sep 27, 2023 08:29

Stifel analyst Stephen Willey maintains MEI Pharma (NASDAQ:MEIP) with a Hold and lowers the price target from $10 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment